Interesting facts
              Interesting Facts about (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
The compound known as (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol is a fascinating molecule with several noteworthy characteristics that intrigue both chemists and researchers alike:
- Stereochemistry: This compound exhibits specific stereochemistry with multiple stereocenters, contributing to distinct spatial arrangements that can affect its biological activity and interactions.
 - Biological Relevance: Due to its structure, this compound may function as a pivotal intermediate in various biochemical pathways, particularly those involving amino sugars or polyols.
 - Pharmaceutical Potential: The presence of a methylamino group suggests potential uses in medicinal chemistry, where such molecules can exhibit intriguing pharmacological properties.
 - Chirality: The chirality of this compound can lead to different biological efficacy and safety profiles. It demonstrates the critical importance of considering enantiomers in drug design.
 - Applications in Synthesis: This type of pentol may also serve as a precursor for synthesizing other complex molecules, highlighting its importance in organic synthesis.
 
As highlighted by the great chemist Linus Pauling, "The structure of a substance is a critical determinant of its function." This notion emphasizes the significance of comprehending the structure of (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol in various scientific fields, from pharmaceuticals to biochemistry.
Overall, the study of this compound not only broadens our understanding of organic chemistry and stereochemistry but also underscores the intricate connections between molecular structure and biological activity.
Synonyms
          meglumine
          N-Methyl-D-glucamine
          6284-40-8
          N-Methylglucamine
          Meglumin
          1-Deoxy-1-(methylamino)-D-glucitol
          D-Glucitol, 1-deoxy-1-(methylamino)-
          Meglumina
          Methylglucamine
          N-Methylsorbitylamine
          Megluminum
          1-Deoxy-1-methylaminosorbitol
          (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
          Megluminum [INN-Latin]
          Meglumina [INN-Spanish]
          (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentaol
          Sorbitol, 1-deoxy-1-methylamino-
          d(-)-n-methylglucamine
          6HG8UB2MUY
          EINECS 228-506-9
          N-Methyl-D(-)-glucamine
          Meglumine [USP:INN:BAN:JAN]
          MEGLUMINE [INN]
          MEGLUMINE [JAN]
          MEGLUMINE [II]
          NSC-7391
          MEGLUMINE [VANDF]
          NSC-52907
          MEGLUMINE [MART.]
          MEGLUMINE [USP-RS]
          MEGLUMINE [WHO-DD]
          MEGLUMINE [WHO-IP]
          N-METHYLGLUCAMINE [MI]
          MEGLUMINE [ORANGE BOOK]
          DTXSID0023244
          MEGLUMINE [EP MONOGRAPH]
          CHEBI:59732
          MEGLUMINE [USP MONOGRAPH]
          EC 228-506-9
          NSC52907
          MEGLUMINE (II)
          NSC 7391
          Megluminum (INN-Latin)
          Meglumina (INN-Spanish)
          NSC 52907
          MEGLUMINE (MART.)
          MEGLUMINE (USP-RS)
          Glucitol, 1-deoxy-1-(methylamino)-, D-
          DTXCID503244
          MEGLUMINE (EP MONOGRAPH)
          MEGLUMINE (USP MONOGRAPH)
          Meglumine (USP:INN:BAN:JAN)
          C7H17NO5
          UNII-6HG8UB2MUY
          MFCD00004707
          NSC7391
          1-deoxy-1-methylamino-d-glucitol
          N-methyl-glucamine
          N-Methyl glucamine
          NCGC00166125-01
          CAS-6284-40-8
          Meglumine (Standard)
          Meglumine (Excipient)
          antimoniate de mAglumine
          SCHEMBL2193
          BIDD:GT0676
          METHYLGLUCAMINE [INCI]
          Meglumine (JP17/USP/INN)
          CHEMBL1200570
          HY-B0342A
          HY-B0342R
          P01CB01
          MEGLUMINUM [WHO-IP LATIN]
          1-deoxy-1-(methylamino)-glucitol
          1-Methylamino-1-deoxy-D-glucitol
          HMS2089B05
          HMS3714B10
          Pharmakon1600-01300029
          HY-B0342
          Tox21_112330
          Tox21_302037
          NSC759607
          s1974
          AKOS005167162
          AKOS015850890
          N-methyl-1-amino-1-deoxy-D-glucitol
          Tox21_112330_1
          AC-4692
          CCG-220884
          MM07027
          NSC-759607
          RP10191
          Meglumine 100 microg/mL in Acetonitrile
          NCGC00166125-02
          NCGC00255365-01
          AC-17087
          AS-12002
          SBI-0206683.P002
          1-Deoxy-1-methylamino-D-glucitol;Meglumine
          Meglumine, meets USP testing specifications
          M0227
          SW199350-2
          D01796
          AB00430469-03
          AB00430469_05
          EN300-2394659
          Q288875
          SR-05000001446
          N-Methyl-D-glucamine, 99.0-100.5% (titration)
          SR-05000001446-1
          BRD-K28595280-001-01-1
          BRD-K28595280-001-03-7
          BRD-K28595280-001-04-5
          BRD-K28595280-001-05-2
          N-Methyl-D-glucamine, Vetec(TM) reagent grade, 99%
          N-Methyl-D-glucamine, ReagentPlus(R), >=99.0% (T)
          Z1255485274
          (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentaol
          Meglumine, United States Pharmacopeia (USP) Reference Standard
          N-methyl-(2 (S),3 (R),4 (R),5 (R),6-pentahydroxy-hexyl)-amine
          Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material
          N-Methyl-D-glucamine, European Pharmacopoeia (EP) Reference Standard
          228-506-9
              
Solubility of (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
The solubility of (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol is influenced by several factors, predominantly its functional groups and structural characteristics. This compound is a type of sugar alcohol or polyol, which often exhibits the following solubility traits:
In summary, the solubility profile of (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol indicates strong compatibility with aqueous environments while demonstrating challenges when interacting with non-polar solvents. As stated, “the more hydroxyl groups present, the more soluble the compound typically becomes!”